BEONE MEDICINES LTD. Interest Income (Expense), Nonoperating, Net
BEONE MEDICINES LTD. (ONC) reported Interest Income (Expense), Nonoperating, Net of $3.03 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2025-11-06
- BEONE MEDICINES LTD. interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was $3.03M, a 71.54% decline year-over-year.
- BEONE MEDICINES LTD. interest income (expense), nonoperating, net for the quarter ending 2025-06-30 was $3.50M, a 73.56% decline year-over-year.
- BEONE MEDICINES LTD. interest income (expense), nonoperating, net for the quarter ending 2025-03-31 was $5.85M, a 63.81% decline year-over-year.
- BEONE MEDICINES LTD. interest income (expense), nonoperating, net for the quarter ending 2024-12-31 was $7.81M, a 52.02% decline year-over-year.
- BEONE MEDICINES LTD. interest income (expense), nonoperating, net for fiscal 2024 was $47.84M, a 35.36% decline from fiscal 2023.
- BEONE MEDICINES LTD. interest income (expense), nonoperating, net for fiscal 2023 was $74.01M, a 41.02% increase from fiscal 2022.
- BEONE MEDICINES LTD. interest income (expense), nonoperating, net for fiscal 2022 was $52.48M.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2025-09-30 | $3.03M 10-Q · filed 2025-11-06 | $6.53M derived: sum of 2 quarters · filed 2025-11-06 | $12.37M 10-Q · filed 2025-11-06 | $20.18M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | $3.50M 10-Q · filed 2025-08-06 | $9.35M 10-Q · filed 2025-08-06 | $17.15M derived: sum of 3 quarters · filed 2025-08-06 | $27.80M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-03-31 | $5.85M 10-Q · filed 2025-05-07 | $13.66M derived: sum of 2 quarters · filed 2025-05-07 | $24.30M derived: sum of 3 quarters · filed 2025-11-06 | $37.52M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-12-31 | $7.81M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $18.45M derived: sum of 2 quarters · filed 2025-11-06 | $31.68M derived: sum of 3 quarters · filed 2025-11-06 | $47.84M 10-K · filed 2025-02-27 |
| 2024-09-30 | $10.64M 10-Q · filed 2025-11-06 | $23.87M derived: sum of 2 quarters · filed 2025-11-06 | $40.03M 10-Q · filed 2025-11-06 | $56.30M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $13.22M 10-Q · filed 2025-08-06 | $29.39M 10-Q · filed 2025-08-06 | $45.66M derived: sum of 3 quarters · filed 2025-08-06 | $72.31M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $16.16M 10-Q · filed 2025-05-07 | $32.43M derived: sum of 2 quarters · filed 2025-05-07 | $59.08M derived: sum of 3 quarters · filed 2025-05-07 | |
| 2023-12-31 | $16.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $42.92M derived: sum of 2 quarters · filed 2025-02-27 | $74.01M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $26.65M 10-Q · filed 2024-11-12 | $57.73M 10-Q · filed 2024-11-12 | ||
| 2022-12-31 | $52.48M 10-K · filed 2025-02-27 |